(Q33509456)

27 July 2017

title

Cilostazol, a specific PDE-3 inhibitor, ameliorates chronic ileitis via suppression of interaction of platelets with monocytes (English)

1 reference

27 July 2017

1 reference

Masaaki Higashiyama

3

0 references

author name string

Hisayuki Matsunaga

1

1 reference

27 July 2017

Ryota Hokari

2

1 reference

27 July 2017

Chie Kurihara

4

1 reference

27 July 2017

Yoshikiyo Okada

5

1 reference

27 July 2017

Chikako Watanabe

6

1 reference

27 July 2017

Shunsuke Komoto

7

1 reference

27 July 2017

Mitsuyasu Nakamura

8

1 reference

27 July 2017

Atsushi Kawaguchi

9

1 reference

27 July 2017

Shigeaki Nagao

10

1 reference

27 July 2017

Soichiro Miura

11

1 reference

27 July 2017

publication date

8 October 2009

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

27 July 2017

published in

1 reference

27 July 2017

volume

297

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

G1077-84

1 reference

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Are phosphodiesterase 4 inhibitors just more theophylline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Sildenafil in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

P-selectin-dependent monocyte recruitment through platelet interaction in intestinal microvessels of LPS-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor-null mice fed high cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

The key role of macrophages in the immunopathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Piroxicam accelerates development of colitis in T-cell receptor alpha chain-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Attenuation of gastric mucosal inflammation induced by aspirin through inhibition of selective type III phospshodiesterase in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Rolipram inhibits leukocyte-endothelial cell interactions in vivo through P- and E-selectin downregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Hypercholesterolemia promotes P-selectin-dependent platelet-endothelial cell adhesion in postcapillary venules

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Cilostazol, a phosphodiesterase inhibitor, reduces microalbuminuria in the insulin-resistant Otsuka Long-Evans Tokushima Fatty rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00240.2009

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00240.2009

1 reference

27 July 2017

1 reference